Epigno
AcquiredTokyo, JP · 2 known investors
Epigno develops management systems for medical and nursing care institutions and provides related consulting services. The company serves healthcare and elderly-care organizations in Japan.
Also known as Epigno Co., Ltd. · Epigno Inc. · エピグノ · 株式会社エピグノ
Founders & leadership
Investors · 2
Company profile
researched Aug 2026Epigno Co., Ltd. (株式会社エピグノ) is a Tokyo-based company that develops human-resources and workforce management software specialised for medical and nursing care institutions, together with related consulting services. Its stated mission is "all for future patients and families," and the company name derives from the Ancient Greek "Epignosis" (wisdom). The product line spans staff skill and evaluation management, engagement and motivation measurement, and automated scheduling, and is positioned as a healthcare-vertical management solution addressing not only individual staff appraisal and training but also organisation-level engagement and motivation.
The company markets at least three named products. Epital HR targets hospitals and other medical institutions, centralising staff records, measuring individual and organisational motivation/engagement, and generating shift rosters and Japan's Form 9 (様式9) staffing filings automatically using AI. Epitaku applies the same model to home-care/home-visit medical and nursing organisations, covering skill visualisation, optimal staff allocation, motivation measurement and AI shift creation. Epiope focuses on operating-room nurses, managing their experience and skills, auto-generating complex OR nurse shifts subject to constraints such as preceptor arrangements, NG pairings and staff preferences, and automatically assigning nurses to scheduled surgeries based on experience data to support patient safety. Each product is offered alongside a business-improvement consulting plan that maps and visualises existing workflows and supports implementation of efficiency measures before software rollout.
Epigno reports capital of ¥282.5 million (including capital reserve), a headcount of 20 including outside directors, and a Japanese fee-charging employment placement licence (13-ユ-314718). It is headquartered in the Kasumigaseki Building, Chiyoda-ku, Tokyo, and was established on 2 September 2016. In June 2025 listed healthcare group EUCALIA Inc. agreed to acquire the company, which became a Eucalia subsidiary.
Founding story
The company's name is drawn from the Ancient Greek "Epignosis," meaning wisdom, reflecting the intent to provide wisdom that supports medical and nursing care institutions, under the mission "all for future patients and families."
Business model
Epigno sells subscription-style management software to healthcare and nursing-care provider organisations, with onboarding delivered through a defined implementation flow (application, initial data entry, account issuance, site rollout, operation). Software is complemented by paid consulting engagements for workflow analysis and efficiency improvement, and the company holds a licence for fee-charging employment placement services.
Software products for medical and nursing care institutions plus consulting services. For the period ending 31 August 2024, Epigno reported total revenue of approximately ¥110 million with an operating loss of ¥83.7 million and a net loss of ¥81.19 million.
Traction
The company reported that combined users of Epital HR and Epitaku surpassed 10,000 in January 2025. Reported revenue for the year to 31 August 2024 was approximately ¥110 million, with net assets of ¥23.3 million and total assets of approximately ¥190 million.
Latest developments
In January 2025 Epigno announced that Epital HR and Epitaku together passed 10,000 users; in February 2025 its CMO Shiga spoke at SENDAI for Startups! 2025. In June 2025 EUCALIA Inc. agreed to acquire the company and Epigno became a Eucalia subsidiary under a share transfer agreement, with Inui continuing as representative. A revision to the company's privacy policy was announced in January 2026.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
A healthcare-vertical startup in Japan's medical and nursing-care HR software segment, addressing widespread paper-based staff record keeping (cited as 67.8% of information managed on paper) and staff dissatisfaction with management. Following the 2025 transaction it sits within EUCALIA Inc., a listed Japanese healthcare group operating medical management support, senior care and medical device segments.
Specialisation in the medical and nursing care vertical rather than generic HR software: products encode sector-specific requirements such as Japan's Form 9 staffing filings, operating-room nurse assignment tied to surgical safety, preceptor and NG-pair scheduling constraints, and home-care staff allocation, combined with engagement/motivation measurement and optional workflow consulting.
Technology
AI-based automation applied to healthcare workforce management: automatic shift/roster generation under complex constraints (staff preferences, skill sets, preceptor rules, prohibited pairings), automatic assignment of nurses to scheduled surgeries based on recorded experience and skills, automated preparation of Form 9 staffing filings, centralised staff/skill databases and quantitative measurement of staff motivation and organisational engagement.
Go-to-market
Direct sales of product-specific solutions (Epital HR, Epitaku, Epiope) to institution types, with a pre-implementation consulting offer used as an entry point; visibility is also sought through startup and industry events, such as a CMO speaking appearance at SENDAI for Startups! 2025.
Hospitals and other medical institutions, home-visit medical and nursing care providers, and operating-room nursing departments in Japan; buyers are typically management and nursing administrators responsible for staff evaluation, allocation and scheduling.
Geography
Japan-focused, headquartered in Chiyoda-ku, Tokyo (Kasumigaseki Building), with activity also noted in the Sendai startup ecosystem.
History
Established 2 September 2016. The company built a portfolio of healthcare-specific HR management products and by January 2025 reported more than 10,000 users across Epital HR and Epitaku. On 5 June 2025 EUCALIA Inc. (TSE:286A) signed an agreement to acquire Epigno from a shareholder group that included M3, Inc. (19.9%), M3 Career, Inc. (9.4%), THVP-No. 1 Limited Partnership managed by Tohoku University Venture Partners (11.7%), Fumiyoshi Inui (22.5%), Takuya Shiga (12.1%), plus Lifetime Ventures Investment LP, Kanshin Mirai No.2 Investment LP, Healthcare New Frontier Investment LP and Colopl Next No.7 Fund Investment LP; the deal was expected to close on 1 July 2025. Representative director Inui remained as Epigno's representative after the acquisition.
Risks & controversies
Financial results disclosed in connection with the acquisition show the business was loss-making, with an operating loss of ¥83.7 million and a net loss of ¥81.19 million on roughly ¥110 million of revenue for the period ending 31 August 2024, and net assets of ¥23.3 million. The company operates as a small team (20 people including outside directors) and is now dependent on its parent group's resources and strategy.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 5
launches, deals, and filingsEpigno announced a revision of its personal information protection policy (privacy policy).
EUCALIA Inc. (TSE:286A) signed an agreement on 5 June 2025 to acquire Epigno Inc. from a group of shareholders including M3, Inc. (19.9%), M3 Career, Inc. (9.4%), THVP-No. 1 Limited Partnership managed by Tohoku University Venture Partners (11.7%), Fumiyoshi Inui (22.5%), Takuya Shiga (12.1%), Lifetime Ventures Investment LP, Kanshin Mirai No.2 Investment LP, Healthcare New Frontier Investment LP and Colopl Next No.7 Fund Investment LP. The transaction was expected to close on 1 July 2025.
Epigno announced that its CMO, Shiga, appeared as a speaker at the SENDAI for Startups! 2025 event.
Epigno announced that the combined number of users of its Epital HR and Epitaku products exceeded 10,000.
Epigno Inc. concluded a share transfer agreement with Eucalia Inc., becoming a subsidiary of the Eucalia Group; the stated rationale was to use the group's management resources to address issues faced by medical and nursing care institutions. Epigno's executive officer and representative director, Inui, continued to serve as Epigno's representative and to work on expanding both companies' businesses.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Epignoepigno.jp · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Epigno do?
- Japanese vertical SaaS company providing HR and workforce management systems for medical and nursing care institutions.
- Who are Epigno's investors?
- Epigno's investors include Colopl Next, Lifetime Ventures.
- Where is Epigno headquartered?
- Epigno is headquartered in Tokyo, JP.